The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bot, A.
Right arrow Articles by Bona, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bot, A.
Right arrow Articles by Bona, C.
The Journal of Immunology, 1998, 160: 4500-4507.
Copyright © 1998 by The American Association of Immunologists

Cellular Mechanisms Involved in Protection Against Influenza Virus Infection in Transgenic Mice Expressing a TCR Receptor Specific for Class II Hemagglutinin Peptide in CD4+ and CD8+ T Cells1

Adrian Bot*, Sofia Casares*, Simona Bot*, Harald von Boehmer{dagger} and Constantin Bona2,*

* Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029; and {dagger} Institut Necker, Institut National de la Santé et de la Recherche Médicale U373, Paris, France

Mice transgenic for a TCR that recognizes peptide110–120 of hemagglutinin of PR8 influenza virus in the context of MHC class II I-Ed molecules express the transgenes in both CD4+ and CD8+ T cells. We have found that these TCR-hemagglutinin (TCR-HA) transgenic mice display a significantly increased resistance to the primary infection with PR8 virus compared with the wild-type mice. The TCR-HA transgenic mice mounted significant MHC type II and enhanced MHC type I-restricted cytotoxicity as well as increased cytokine responses in both spleen and lungs after infection with PR8 virus. In contrast, the primary humoral response against PR8 virus was not significantly different from that of the wild-type mice. In vivo depletion and adoptive cell transfer experiments demonstrated that both CD4+ and CD8+ TCR-HA+ T cell subsets were required for the complete clearance of pulmonary virus following infection with a dose that is 100% lethal in wild-type mice. Whereas CD4+ TCR-HA+ T cells were necessary for effective activation and local recruitment of CD8+ T cells, CD8+ TCR-HA+ T cells showed a Th1-biased pattern and MHC type II-restricted cytotoxicity. However, in the absence of in vivo expression of MHC type I molecules on the infected cells, the protection conferred by the TCR-HA+ T cells was impaired, indicating that the enhanced MHC class I-restricted cytotoxicity due to TCR-HA+ CD4+ Th cells was a critical element for clearance of the pulmonary virus by the transgenic mice.




This article has been cited by other articles:


Home page
Int ImmunolHome page
T. Ebihara, H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
Int. Immunol., October 1, 2007; 19(10): 1145 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Rharbaoui, D. Bruder, M. Vidakovic, T. Ebensen, J. Buer, and C. A. Guzman
Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues
J. Immunol., February 1, 2005; 174(3): 1317 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. J. Novak, S. A. Masewicz, A. W. Liu, A. Lernmark, W. W. Kwok, and G. T. Nepom
Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset
Int. Immunol., June 1, 2001; 13(6): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Casares, C. S. Zong, D. L. Radu, A. Miller, C. A. Bona, and T.-D. Brumeanu
Antigen-specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation
J. Exp. Med., August 16, 1999; 190(4): 543 - 554.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Maloy, C. Burkhart, G. Freer, T. Rulicke, H. Pircher, D. H. Kono, A. N. Theofilopoulos, B. Ludewig, U. Hoffmann-Rohrer, R. M. Zinkernagel, et al.
Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection
J. Immunol., March 1, 1999; 162(5): 2867 - 2874.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bot, S. Bot, and C. A. Bona
Protective Role of Gamma Interferon during the Recall Response to Influenza Virus
J. Virol., August 1, 1998; 72(8): 6637 - 6645.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.